(Q38028326)

27 August 2017

0 references

An updated systematic review and meta-analysis on the treatment of active tuberculosis in patients with HIV infection (English)

1 reference

27 August 2017

0 references

1 reference

1 reference

6

Dick Menzies

1 reference

27 August 2017

5

Anthony D Harries

1 reference

27 August 2017

Faiz Ahmad Khan

1

1 reference

27 August 2017

Jessica Minion

series ordinal

2

1 reference

27 August 2017

Abdullah Al-Motairi

series ordinal

3

1 reference

27 August 2017

Andrea Benedetti

series ordinal

4

1 reference

27 August 2017

language of work or name

English

0 references

publication date

19 July 2012

1 reference

Clinical Infectious Diseases

27 August 2017

published in

1 reference

27 August 2017

volume

55

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

1154-1163

1 reference

Increased mortality and tuberculosis treatment failure rate among human immunodeficiency virus (HIV) seropositive compared with HIV seronegative patients with pulmonary tuberculosis treated with "standard" chemotherapy in Kinshasa, Zaire

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Relapse in persons treated for drug-susceptible tuberculosis in a population with high coinfection with human immunodeficiency virus in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampin-based treatment: an analytical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Risk factors for relapse and acquired rifamycin resistance after directly observed tuberculosis treatment: a comparison by HIV serostatus and rifamycin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Treatment outcomes of patients with HIV and tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Prevalence and risk factors associated with drug resistant TB in South West, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clini

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

The binomial distribution of meta-analysis was preferred to model within-study variability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Effectiveness of early antiretroviral therapy initiation to improve survival among HIV-infected adults with tuberculosis: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga district hospital in 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Impact of HIV Infection on the Recurrence of Tuberculosis in South India

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

High rates of recurrence in HIV-infected and HIV-uninfected patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Human immunodeficiency virus and the outcome of treatment for new and recurrent pulmonary tuberculosis in African patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

HIV-1 and recurrence, relapse, and reinfection of tuberculosis after cure: a cohort study in South African mineworkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-1-infected individuals: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Timing of initiation of antiretroviral drugs during tuberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS630

21 January 2018

Identifiers

DOI

10.1093/CID/CIS630

1 reference

27 August 2017

1 reference